Publications 2025

Cochrane reviews - published

  1. Cagnotto G, Bruschettini M, Stróżyk A, Scire CAlberto, Compagno M. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis. Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD013614
  2. Cagnotto G, Juhl CB, Ahlström F, Wikström F, Bruschettini M, Petersson I, Dreyer L, Compagno M. Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD013715
  3. Urlesberger B, Cabano R, Soll G, Oei JL, Pahl A, Schmölzer GM, Bruschettini M. Acupuncture for neonatal abstinence syndrome in newborn infants. Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD014160
  4. King E, Horn D, Gluchowski N, Bruschettini M, Fiander M, Soll R, O'Reilly D. Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease. Cochrane Database of Systematic Reviews 2025, Issue 3. Art. No.: CD015127
  5. Färnqvist K, Bruschettini M, Olsson E, Garratt A, Paraskevas T, Soll R, Persad E. Clinical rating scales for assessing pain in newborn infants. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: MR000064
  6. Cabano R, Abdallat  H, Abuhammour R, Soll G, Oei JL, Schmölzer GM, Bruschettini M. Acupuncture for procedural pain in newborn infants. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: CD015894
  7. Romantsik O, Sharifan A, Fiander M, Ng E, Bruschettini M. Midazolam for sedation of infants in the neonatal intensive care unit. Cochrane Database of Systematic Reviews 2025, Issue 7. Art. No.: CD002052
  8. Bruschettini M, Moberg T, O'Donnell CP, Davis PG, Morley CJ, Moja L, Calevo MG. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. Cochrane Database of Systematic Reviews 2025, Issue 7. Art. No.: CD004953
  9. Borys F, Wróblewska-Seniuk K, Fiander M, Soll R, Ringsten M, Bruschettini M, Sibrecht G. Indications and timing for caffeine initiation in preterm infants. Accepted for publication, October 2025
  10. Darlison P, Moresco L, Bruschettini M, Nussbaumer-Streit B, Gisselsson-Solen M. Decongestants and antihistamines for acute otitis media in children. Accepted for publication, October 2025

 

Cochrane reviews - submitted

  1. Bodrero E, Isaza Lopez MC, Greisen G, Gluud C, Bruschettini M. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants. Submitted February 2025

 

Cochrane reviews in preparation:

  1. Kinoshita M, Del Giovane C, Borys F, Mitra S, Hall R, Wróblewska-Seniuk K, Soll R, Bruschettini M. Methylxanthine for preventing morbidity and mortality in preterm infants: a network meta-analysis. Cochrane Database of Systematic Reviews 2023, Issue 12. Art. No.: CD015058
  2. Olsson E, Sibrecht G, Conde-Agudelo A, Díaz-Rossello JL, Ehret D, Bruschettini M. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
  3. Urru S, Geist M, Carlinger R, Bodrero E, Giordano P, Bruschettini M. Strategies for cessation of caffeine administration in preterm infants. Update 2025
  4. O'Reilly D, Fiander M, Bruschettini M, Soll R. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Update 2025
  5. Wróblewska-Seniuk K, Lenells M, Prescott Glenton M, Fiander M, Soll R, Bruschettini M. Multisensorial stimulation for promoting development and preventing morbidity in preterm infants.
  6. Lenells M, Prescott Glenton M, Wróblewska-Seniuk K, Fiander M, Soll R, Bruschettini M. Olfactory stimulation for promoting development and preventing morbidity in preterm infants.
  7. Prescott Glenton M, Wróblewska-Seniuk K, Lenells M, Fiander M, Soll R, Bruschettini M. Vestibular stimulation for promoting development and preventing morbidity in preterm infants.
  8. Nissimov S, Sibrecht G, Weerasekara I, Bartocci M, Bruschettini M. Minimizing blood sampling in preterm infants.
  9. Bodrero E, Isaza C, Fiander M, Soll R, Bruschettini M. Methylxanthines for the prevention or treatment of intermittent hypoxemia or respiratory insufficiency in late preterm infants.
  10. Prescott Glenton M, Geist M, Olsson E, Fiander M, Soll R, Bruschettini M. Infant positioning for promoting development and preventing morbidity in preterm infants.
  11. Wróblewska-Seniuk K, Wallman-Stokes A, Edwards E, Fiander M, Bruschettini M, Soll R. Financial incentives for family members of hospitalized neonates for improving family engagement.
  12. Borys F, Prescott Glenton M, Fiander M, Soll R, Bruschettini M. Clustering of nursery care activities for promoting development and preventing morbidity in preterm infants.
  13. Moresco L, Bruschettini M, Macchi M, Calevo MG. Salbutamol for transient tachypnea of the newborn (third update)

 

Cochrane protocols - published

  1. Olsson E, Prescott Glenton M, Titlestad KBerg, Fiander M, Soll R, Bruschettini M. Individualized developmental care interventions for promoting development and preventing morbidity in preterm infants. Cochrane Database of Systematic Reviews 2025, Issue 1. Art. No.: CD016026
  2. Badura A, Faas D, Gabriel A, Wellmann S, Cracknell J, Fiander M, Soll R, Bruschettini M. In-hospital motor interventions to prevent neurodevelopmental impairment in preterm infants: a scoping review. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: CD016181
  3. Pessara S, Boldor M, Faravelli F, Fiander M, Jørgensen KJ, Soll RF, Bruschettini M. Next-Generation Sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: CD016118
  4. Bäcke P, Thernström Blomqvist Y, Björk M, Fiander M, Soll R, Bruschettini M. Training to increase parental participation in care decisions and delivery for infants in neonatal units. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: CD014837
  5. Borys F, Bruschettini M, Sibrecht G, Mohammad Khuzaini A, Fiander M, Soll R. Higher initial doses of surfactant for the prevention or treatment of respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: CD016180
  6. Badura A, Hiekel J, Saladino A, Murature D, Wellmann S, Fiander M, Bruschettini M. Motor interventions initiated prior hospital discharge to prevent neurodevelopmental impairment in preterm infants. Cochrane Database of Systematic Reviews 2025, Issue 5. Art. No.: CD016170
  7. Olsson E, Romantsik O, Lundgren P, Fiander M, Snellman A, Hellstrom A, Bruschettini M. Pain management for screening or treatment of retinopathy of prematurity. Cochrane Database of Systematic Reviews 2025, Issue 5. Art. No.: CD016171
  8. Garegnani L, Escobar Liquitay CM, Esteban I, Russo C, Bruschettini M, Franco J. Monoclonal antibodies for preventing respiratory syncytial virus infection in children. A network meta-analysis. Cochrane Database of Systematic Reviews 2025, Issue 8. Art. No.: CD016224
  9. Cagnotto C, Bäcklund R, Bengtsson A, Bruschettini M. Immunosuppressants and immunomodulators for IgG4-related disease. Cochrane Database of Systematic Reviews 2025, Issue 8. Art. No.: CD016094
  10. Sotiropoulos J, Soll R, Fiander M, Bruschettini M, Oei JL; Kapadia V, Seidler AL. Delivery room oxygen titration strategies to improve preterm infant outcomes. Cochrane Database of Systematic Reviews 2025, Issue 8. Art. No.: CD016293
  11. Weerasekara I, Styrmisdóttir L, Ringsten M, Orsini N, Andersson O, Mukiira C, Sharma S, Fiander M, Andersson A, Vaag A, Nilsson PM, Bruschettini M. Birth weight and prematurity for predicting type 2 diabetes mellitus: a prognostic review. Cochrane Database of Systematic Reviews 2025, Issue 9. Art. No.: CD016154
  12. Lööf E, Skogman Hedin B, Cabano R, Sylvan R, Bruschettini M. Acupuncture for the treatment of infantile colic. Cochrane Database of Systematic Reviews 2025, Issue 10. Art. No.: CD016305
  13. Bolanos L, Borys F, Pahl A, Fiander M, Cracknell J, Gautham KS, Soll RF, Bruschettini M. Intratracheal instillation of corticosteroids combined with surfactant for the prevention of chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews 2025, Issue 10. Art. No.: CD016024

 

Cochrane protocols - submitted

  1. Wróblewska-Seniuk K, Arham M, Geist M, Björklund M, Rose CJ, Sibrecht G, Borys F, Bruschettini M. Neonatal morbidity in late preterm and early term infants. Submitted August 2025

Cochrane protocols in preparation:

  1. Darlison P, Bruschettini M, Gisselsson-Solén M, Jenniskens K, Hooft L. Artificial intelligence for diagnosing acute otitis media.
  2. Fink A, Berg M, Soll R, Fiander M, Hunter K, Aagerup J, Sotiropoulos J, Cracknell J, Bruschettini M, Seidler AL. Therapeutic hypothermia for newborns with hypoxic ischemic encephalopathy
     

Peer-reviewed articles in other Journals

  1. Wilkinson J, Heal C, Antoniou GA, Flemyng E, Ahnström L, Alteri A, Avenell A, Barker TH, Borg DN, Brown NJ, Buhmann R, Calvache JA, Carlsson R, Carter LA, Cashin AG, Cotterill S, Färnqvist K, Ferraro MC, Grohmann S, Gurrin LC, Hayden JA, Hunter KE, Hyltse N, Jung L, Krishan A, Laporte S, Lasserson TJ, Laursen DR, Lensen S, Li W, Li T, Liu J, Locher C, Lu Z, Lundh A, Marsden A, Meyerowitz-Katz G, Mol BW, Munn Z, Naudet F, Nunan D, O'Connell NE, Olsson N, Parker L, Patetsini E, Redman B, Rhodes S, Richardson R, Ringsten M, Rogozińska E, Seidler AL, Sheldrick K, Stocking K, Sydenham E, Thomas H, Tsokani S, Vinatier C, Vorland CJ, Wang R, Al Wattar BH, Weber F, Weibel S, van Wely M, Xu C, Bero L, Kirkham JJ. Assessing the feasibility and impact of clinical trial trustworthiness checks via an application to Cochrane Reviews: Stage 2 of the INSPECT-SR project. J Clin Epidemiol. 2025 May 9:111824. doi: 10.1016/j.jclinepi.2025.111824.
  2. Ringsten M, Färnqvist K, Bruschettini M, Johansson M. Inclusion, characteristics and methodological limitations of systematic reviews in doctoral theses: A cross-sectional study of all universities in Sweden. Cochrane Evidence Synthetis and Methods;3:e70015
  3. Nilsonne G, Wieschowski S, DeVito NJ, Salholz-Hillel M, Ahnström L, Bruckner T, Klas K, Suljic T, Yerunkar S, Olsson N, Cruz C, Strzebonska K, Småbrekke L, Wasylewski MT, Bengtsson J, Ringsten M, Schuster A, Krawczyk T, Paraskevas T, Raittio E, Herczeg L, Hesselberg JO, Karlsson S, Borana R, Bruschettini M, Mulinari S, Lizárraga K, Siebert M, Hildebrand N, Ramakrishnan S, Janiaud P, Zavalis E, Franzen D, Boesen K, Hemkens LG, Naudet F, Possmark S, Willén RM, Ioannidis JP, Strech D, Axfors C. Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed. Journal of Clinical Epidemiology, Feb 1:111710. doi: 10.1016/j.jclinepi.2025.111710.
  4. Rose C, Geist M, Bruschettini M. Count data, rates, rate differences, and rate ratios in meta-analysis: A tutorial. Cochrane Evidence Synthesis and Methods 2025; 3:e70022.
  5. Rose CJ, Bidonde J, Ringsten M, Glanville J, Berg RC, Cooper C, Muller AE, Bergsund HB, Meneses-Echavez JF, Potrebny T. Using a large language model (ChatGPT) to assess risk of bias in randomized controlled trials of medical interventions: protocol for a pilot study of interrater agreement with human reviewers. BMC Med Res Methodol. 2025 Jul 31;25(1):182. doi: 10.1186/s12874-025-02631-0
  6. Shcherbatiuk K, Magagnoli C, Susca F, Caratozzolo D, Fiander M, Soll RF, Bruschettini M, Romantsik O. Devices to improve success of peripheral vascular catheterization in newborn infants. Neonatology, accepted for publication October 2025
  7. Rose C, Bruschettini M. Count outcomes, rate ratios, and rate differences. BMJ EBM. BMJ EBM, accepted for publication October 2025
  8. Rogova O, Herzog K, Carolo dos Santos K, Frilund JP, Al-Majdoub M, Bruschettini M, Ley D, Spégel P. Absence of caffeine impact on hepatic metabolism in healthy conditions: Insights from human cross-sectional studies, in vivo and in vitro experiments. Nutrition Research, submitted March 2025
  9. Ringsten M, Styrmisdottir L, Naesström M, Johansson M, Bruschettini M, Wallerstedt SM. Acceptance of systematic reviews within doctoral theses and for promotion to associate professor: A review of policies from all medical faculties in Swedish universities. Cochrane Evidence Synthesis and Methods. Submitted August 2025
  10. AM Osman AAM, Russo C, Rojas-Reyes M, Borys F,  Fiander M, Soll R, Bruschettini M, Sibrecht G. Strategies for caffeine administration in preterm infants. Italian Journal of Pediatrics; Submitted August 2025.
  11. Toews M, Minozzi S, Stegeman BH, Cinquini M, Meerpohl JJ, Färnqvist K, Bruschettini M, Toews I. Rating down for publication bias is rare in Cochrane reviews: a cross sectional study. Cochrane Evidence Synthesis and Methods. Submitted August 2025
  12. Karam S, Zhang Y, Pardo-Hernandez H, Yepes-Nunez JJ, Qaseem A, Akl E, Williams J, Sultan S, Mustafa R, Wiercioch W, Singh J, Bruschettini M, Song Y, Pinto A, Bala M, Bognanni A, Flottorp SA, Morgan R, Guyatt G, Hazlewood G, Alonso-Coello P, Brozek J, Schunemann H. Assessing the Certainty of the Evidence in People’s Values, Utilities and Importance of Outcomes: updated GRADE guidance. Annals of Internal Medicine. Submitted September 2025
  13. Rose CJ, Bidonde J, Ringsten M, Glanville J, Berg RC, Cooper C, Muller AE, Bergsund HB, Meneses-Echavez JF, Potrebny T. Using a large language model (ChatGPT) to assess risk of bias in randomized controlled trials of medical interventions: protocol for a pilot study of interrater agreement with human reviewers. BMC Med Res Methodol. 2025 Jul 31;25(1):182. doi: 10.1186/s12874-025-02631-0. PMID: 40745627; PMCID: PMC12315198.
  14. Rose CJ, Bidonde J, Ringsten M, Glanville J, Potrebny T, Cooper C, Muller AE, Bergsund HB, Meneses-Echavez JF, Berg RC. Using a Large Language Model (ChatGPT-4o) to Assess the Risk of Bias in Randomized Controlled Trials of Medical Interventions: Interrater Agreement With Human Reviewers. Cochrane Evid Synth Methods. 2025 Sep 10;3(5):e70048. doi: 10.1002/cesm.70048